The Rise Of GLP-1 Drugs In just three years, drugs like Ozempic have reshaped how society views the body. They reignited a ...

Have you evaluated the performance of Eli Lilly's (LLY) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of this drugmaker, ...

Patients presenting to the emergency department with esophageal food impaction commonly do not receive an esophageal biopsy to diagnose EoE, representing a missed diagnostic opportunity.

The menopausal transition is a pivotal time in women’s health, bringing about profound hormonal, metabolic and physiologic ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, Leiden Bio Science Park, the ...

For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

The partnership between LillyDirect and Walmart allows patients to pick up Zepbound at Walmart pharmacies at the same self-pay price as online. Sel ...

Eli Lilly and Company announced Wednesday, Oct. 29 a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

During the industry’s onshoring rush of the last nine months, Eli Lilly has been among the most aggressive biopharma compa | Eli Lilly is allotting $3 billion to establish an oral medicines ...